| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC NEGATIVE ION MODE | m22-L025_SO_04 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM Fasnall | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_05 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM Fasnall | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_06 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM Fasnall | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_07 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM GSK2194069 | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_08 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM GSK2194069 | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_02 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:NA | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_03 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:NA | AU |
| HILIC NEGATIVE ION MODE | Blank-80MeOH | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC NEGATIVE ION MODE | Blank-80MeOH_20220211171023 | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC NEGATIVE ION MODE | Blank-80MeOH_20220211180427 | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC NEGATIVE ION MODE | Blank_NoFlow | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC NEGATIVE ION MODE | m22-L025_SO_01 | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_04 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM Fasnall | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_05 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM Fasnall | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_06 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM Fasnall | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_07 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM GSK2194069 | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_08 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:1 uM GSK2194069 | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_02 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_03 | Sample source:BT-474 | [13C2] Acetate:200 uM | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | Blank-80MeOH | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | Blank-80MeOH_20220211171023 | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | Blank-80MeOH_20220211180427 | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | Blank_NoFlow | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
| HILIC POSITIVE ION MODE | m22-L025_SO_01 | Sample source:BT-474 | [13C2] Acetate:NA | Drug Treatment:NA | AU |
Return to study ST003147 main page
Download data matrix(BT-474 cells fed with [13C2] acetate and treated with 1 uM Fasnall or 1 uM GSK2194069 for 24 h HILIC NEGATIVE ION MODE)
Download data matrix(BT-474 cells fed with [13C2] acetate and treated with 1 uM Fasnall or 1 uM GSK2194069 for 24 h HILIC POSITIVE ION MODE)
- Metabolomics Workbench
|